Results 1 to 10 of about 799 (67)

Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients With Allergic Conjunctivitis

Clinical Ophthalmology, 2023
María Cecilia Marini,1 Martín Lucas Berra,2 Fernada Girado,3 Paula Alejandra Albera,4 Melina Sol del Papa,5 María Silvia Passerini,5 Alejandro Javier Aguilar6 1Ophthalmology Service, El Cruce-Nestor Kirchner High Complexity Hospital, Buenos Aires ...
Mélina del Papa, Maria Cecilia Celeste Marini   +1 more
exaly   +4 more sources

A Comparative Study of Efficacy and Tolerability of Bepotastine Besilate (1.5%) and Olopatadine Hydrochloride (0.1%) Eye Drops in Allergic Conjunctivitis in a Tertiary Care Hospital of the Southern Part of India

Asian Journal of Medical Sciences
Background: Allergic conjunctivitis is increasing with the rise in the levels of allergens. Drug therapy is usually needed in addition to avoidance of general allergens to treat this condition.
Vijendra R
exaly   +6 more sources

Bepotastine Besilate Ophthalmic Solution 1.5% for Alleviating Nasal Symptoms in Patients With Allergic Conjunctivitis

Journal of Asthma and Allergy, 2018
Megan E Cavet,1 Paul J Gomes,2 Warner W Carr,3 Jon I Williams4 1Bausch + Lomb, Rochester, NY, 2Ora, Andover, MA, 3Allergy and Asthma Associates of Southern California, Mission Viejo, CA, 4Bausch + Lomb, Irvine, CA, USA Background: Bepotastine besilate ...
Jon Williams, Paul J Gomes
exaly   +4 more sources

Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis

Indian Journal of Ophthalmology, 2021
Purpose: To compare the efficacy and safety of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2%, and Bepotastine besilate 1.5% ophthalmic solutions in the treatment of allergic conjunctivitis. Methods: This is a prospective, observer-masked, comparative
Shruti Ayyappanavar, Sriya Sridhar, Kiran Kumar, C R Jayanthi, Suresh Babu Gangasagara, B L Sujatha Rathod, B Preethi, Preeti Mittal   +7 more
doaj   +2 more sources

Comparative observational analysis of clinical outcomes in patients of vernal keratoconjunctivitis treated with eye drops olopatadine or bepotastine besilate

Journal of Medical Evidence, 2022
Objective: Observation and comparison of resolution of signs and relief of symptoms in patients of Vernal Keratoconjunctivitis (VKC) treated with 0.1% olopatadine eye drops or 1.5% bepotastine besilate eye drops.
Preeti Yadav, Ajai Agrawal, Puneet Dhamija, Anupam Singh, Sanjeev Kumar Mittal, Ramanuj Samanta   +5 more
doaj   +2 more sources

The Efficacy of Bepotastine Besilate Compared With Hydroxyzine Pamoate for Preventing Infusion Reactions to the First Dose of Rituximab in Patients With Non-Hodgkin Lymphoma: Protocol for a Phase II, Double-Blind, Multicenter Randomized Trial

JMIR Research Protocols, 2023
BackgroundRituximab, an anti-CD20 monoclonal antibody, can cause infusion reactions (IRs), especially during the initial rituximab infusion therapy.
Yumi Kitahiro, Kazuhiro Yamamoto, Kimikazu Yakushijin, Takeshi Ioroi, Masaaki Tanda, Kotaro Itohara, Tomohiro Omura, Hironobu Minami, Ikuko Yano   +8 more
doaj   +2 more sources

The crystal structure of bepotastine besilate, C27H31ClN2O6S

Zeitschrift für Kristallographie - New Crystal Structures
C27H31ClN2O6S, triclinic, P1 (no. 1), a = 8.0223(3) Å, b = 9.8143(3) Å, c = 10.2307(4) Å, α = 88.308(3)°, β = 69.000(3)°, γ = 65.970(3)°, V = 680.39(5) Å3, Z = 1, R gt(F) = 0.0406, wRref (F 2) = 0.1165, T = 297 K.
Wang Fengfeng, Luan Lin, Hu Xiaowen, Zhang Caiyu, Liu Yang   +4 more
doaj   +2 more sources

A pharmacoeconomic study of olopatadine hydrochloride 0.1% eye drops and bepotastine besilate 1.5% eye drops in the management of allergic conjunctivitis: A cost-effectiveness analysis

Asian Journal of Medical Sciences
Background: Allergic conjunctivitis (AC) affects 10–20% of the Indian population, necessitating cost-effective treatment strategies. Aims and Objectives: We aimed to evaluate the comparison between the pharmacoeconomic profiles of olopatadine ...
Sudipto Chatterjee , Pritama Paul , Abhishek Bhattacharjee , Soumyadeep Mahapatra   +3 more
doaj   +2 more sources

First report on green electrochemical sensing of bepotastine besilate based on tungsten doped vanadium dioxide nanoparticles: DFT assisted mechanistic insight

Journal of Saudi Chemical Society
A pioneering green electroanalytical sensor was introduced for a precise and environmentally considerate quantification of bepotastine besilate (BPST); a second-generation antihistaminic drug for treating allergic rhinitis and pruritus.
Aliyah S. Alhawiti, Bayan H. Alharbi, Amani Alhifthi, S. Alfadhli, Ahmed H. Jawhari, Razan M. Snari, Alaa A. Bahamran, Nashwa M. El-Metwaly   +7 more
doaj   +2 more sources

Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.1% ophthalmic solution in allergic conjunctivitis

Journal of Dr. NTR University of Health Sciences
Aim: To compare the efficacy of topical bepotastine 1.5% and olopatadine 0.1% ophthalmic solutions in relieving ocular signs and symptoms of mild to moderate allergic conjunctivitis.
Sunkara Charitha, Kavitha Mandalapu, Bhavya Kadiri, Undrakonda Vivekanand   +3 more
doaj   +2 more sources